Update on the genus Trichosporon

被引:127
作者
Chagas-Neto, Thomas C. [1 ]
Chaves, Guilherme M. [1 ]
Colombo, Arnaldo L. [1 ]
机构
[1] Univ Fed Sao Paulo, Div Infect Dis, BR-04037002 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
emergent pathogen; yeast identification; epidemiology; Trichosporon; antifungal drugs;
D O I
10.1007/s11046-008-9136-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Trichosporon spp. are widely distributed in nature and can occasionally belong to the human microbiota. For many years, the unique species of the genus, Trichosporon beigelli, was only known as an environmental and saprophytic fungus occasionally found as the etiological agent of white piedra. However, case reports of invasive trichosporonosis have been frequently published and the genus is currently considered the second most common agent of yeasts disseminated infections. Based on molecular analysis, the taxon T. beigelli was replaced by several species and the taxonomy of the genus was progressively modified. Despite the reported increase of Trichosporon infections refractory to conventional antifungal drugs, there are only a few studies investigating in vitro susceptibility of Trichosporon spp. to new compounds. Difficulties on different species identification as well as the lack of standardized sensitivity tests in vitro, contribute to the limited information available on epidemiology, diagnosis and therapeutics of trichosporonosis.
引用
收藏
页码:121 / 132
页数:12
相关论文
共 87 条
[11]   Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates [J].
Chaturvedi, V ;
Ramani, R ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) :2252-2254
[12]   Internal transcribed spacer sequencing versus biochemical profiling for identification of medically important yeasts [J].
Ciardo, DE ;
Schär, G ;
Böttger, EC ;
Altwegg, M ;
Bosshard, PP .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (01) :77-84
[13]   Outbreak of Candida rugosa candidemia:: an emerging pathogen that may be refractory to amphotericin B therapy [J].
Colombo, AL ;
Melo, ASA ;
Rosas, RFC ;
Salomao, R ;
Briones, MRS ;
Hollis, RJ ;
Messer, SA ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (04) :253-257
[14]   The first echinocandin: caspofungin [J].
Cornely, OA ;
Schmitz, K ;
Aisenbrey, S .
MYCOSES, 2002, 45 :56-60
[15]  
DEHOOGS GS, 2000, ATLAS CLIN FUNGI
[16]   High-throughput detection of pathogenic yeasts of the genus Trichosporon [J].
Diaz, MR ;
Fell, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3696-3706
[17]   Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956
[18]   Reassignment of the basidiomycetous yeasts Trichosporon pullulans to Guehomyces pullulans gen. nov., comb. nov and Hyalodendron lignicola to Trichosporon lignicola comb. nov. [J].
Fell, JW ;
Scorzetti, G .
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2004, 54 :995-998
[19]   Preface - Fungal infections, - Part I - Recent advances in diagnosis, treatment, and prevention of opportunistic mycoses [J].
Walsh, TJ ;
Rex, JH .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (04) :IX-X
[20]   Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia [J].
Fournier, S ;
Pavageau, W ;
Feuillhade, M ;
Deplus, S ;
Zagdanski, AM ;
Verola, O ;
Dombret, H ;
Molina, JM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (12) :892-896